Literature DB >> 2452882

The choline carrier of erythrocytes: location of the NEM-reactive thiol group in the inner gated channel.

R M Krupka1, R Devés.   

Abstract

Choline transport across the human erythrocyte membrane is irreversibly inhibited when N-ethylmaleimide (NEM) reacts with a carrier SH group which is located outside the substrate site, and which is exposed in the inward-facing form of the carrier but prevented from reacting in the outward-facing form. The location of the SH group with respect to the membrane has now been determined by studying the dependence of the NEM-alkylation rate on the intracellular and extracellular pH. The results show that the reactive SH group equilibrates with hydrogen ions in the cytoplasm, but is completely isolated from hydrogen ions in the external medium. With this added evidence it becomes possible to conclude that the SH group is located in the inner gated channel of the choline carrier.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452882     DOI: 10.1007/bf01872818

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  10 in total

1.  Looking for probes of gated channels: studies of the inhibition of glucose and choline transport in erythrocytes.

Authors:  R M Krupka; R Devés
Journal:  Biochem Cell Biol       Date:  1986-11       Impact factor: 3.626

2.  The carrier reorientation step in erythrocyte choline transport: pH effects and the involvement of a carrier ionizing group.

Authors:  R Devés; G Reyes; R M Krupka
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

3.  Evidence for the carrier model of transport from the inhibition by N-ethylmaleimide of choline transport across the human red cell membrane.

Authors:  P A Edwards
Journal:  Biochim Biophys Acta       Date:  1973-06-07

4.  Reaction of internal forms of the choline carrier of erythrocytes with N-ethylmaleimide: evidence for a carrier conformational change on complex formation.

Authors:  R Devés; R M Krupka
Journal:  J Membr Biol       Date:  1981       Impact factor: 1.843

5.  A general kinetic analysis of transport. Tests of the carrier model based on predicted relations among experimental parameters.

Authors:  R Devés; R M Krupka
Journal:  Biochim Biophys Acta       Date:  1979-10-05

6.  Evidence for a two-state mobile carrier mechanism in erythrocyte choline transport: effects of substrate analogs on inactivation of the carrier by N-ethylmaleimide.

Authors:  R Devés; R M Krupka
Journal:  J Membr Biol       Date:  1981       Impact factor: 1.843

7.  Some properties of an SH group essential for choline transport in human erythrocytes.

Authors:  K Martin
Journal:  J Physiol       Date:  1971-03       Impact factor: 5.182

8.  Discrimination of three parallel pathways of lactate transport in the human erythrocyte membrane by inhibitors and kinetic properties.

Authors:  B Deuticke; E Beyer; B Forst
Journal:  Biochim Biophys Acta       Date:  1982-01-04

9.  Effects on transport of rapidly penetrating, competing substrates: activation and inhibition of the choline carrier in erythrocytes by imidazole.

Authors:  R Devés; R M Krupka
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

10.  Characteristics of chloride transport in human red blood cells.

Authors:  R B Gunn; M Dalmark; D C Tosteson; J O Wieth
Journal:  J Gen Physiol       Date:  1973-02       Impact factor: 4.086

  10 in total
  3 in total

1.  The ligand binding site of the synaptosomal choline transporter: a provisional model based on inhibition studies.

Authors:  E Roberts; M Tamaru
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

2.  A multi-substrate single-file model for ion-coupled transporters.

Authors:  A Su; S Mager; S L Mayo; H A Lester
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

3.  Lysosomal sulphate transport is dependent upon sulphydryl groups.

Authors:  H F Chou; M Passage; A J Jonas
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.